pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-3p | ||||||||||||||||||||||||||||
Sequence | 61| UCUAGUAAGAGUGGCAGUCGA |81 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Microarray | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CREBBP | ||||||||||||||||||||
Synonyms | CBP, KAT3A, RSTS, RSTS1 | ||||||||||||||||||||
Description | CREB binding protein | ||||||||||||||||||||
Transcript | NM_001079846 | ||||||||||||||||||||
Other Transcripts | NM_004380 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CREBBP | |||||||||||||||||||||
3'UTR of CREBBP (miRNA target sites are highlighted) |
>CREBBP|NM_001079846|3'UTR 1 CATTGTGAGAGCATCACCTTTTCCCTTTCATGTTCTTGGACCTTTTGTACTGAAAATCCAGGCATCTAGGTTCTTTTTAT 81 TCCTAGATGGAACTGCGACTTCCGAGCCATGGAAGGGTGGATTGATGTTTAAAGAAACAATACAAAGAATATATTTTTTT 161 GTTAAAAACCAGTTGATTTAAATATCTGGTCTCTCTCTTTGGTTTTTTTTTGGCGGGGGGGTGGGGGGGGTTCTTTTTTT 241 TCCGTTTTGTTTTTGTTTGGGGGGAGGGGGGTTTTGTTTGGATTCTTTTTGTCGTCATTGCTGGTGACTCATGCCTTTTT 321 TTAACGGGAAAAACAAGTTCATTATATTCATATTTTTTATTTGTATTTTCAAGACTTTAAACATTTATGTTTAAAAGTAA 401 GAAGAAAAATAATATTCAGAACTGATTCCTGAAATAATGCAAGCTTATAATGTATCCCGATAACTTTGTGATGTTTCGGG 481 AAGATTTTTTTCTATAGTGAACTCTGTGGGCGTCTCCCAGTATTACCCTGGATGATAGGAATTGACTCCGGCGTGCACAC 561 ACGTACACACCCACACACATCTATCTATACATAATGGCTGAAGCCAAACTTGTCTTGCAGATGTAGAAATTGTTGCTTTG 641 TTTCTCTGATAAAACTGGTTTTAGACAAAAAATAGGGATGATCACTCTTAGACCATGCTAATGTTACTAGAGAAGAAGCC 721 TTCTTTTCTTTCTTCTATGTGAAACTTGAAATGAGGAAAAGCAATTCTAGTGTAAATCATGCAAGCGCTCTAATTCCTAT 801 AAATACGAAACTCGAGAAGATTCAATCACTGTATAGAATGGTAAAATACCAACTCATTTCTTATATCATATTGTTAAATA 881 AACTGTGTGCAACAGACAAAAAGGGTGGTCCTTCTTGAATTCATGTACATGGTATTAACACTTAGTGTTCGGGGTTTTTT 961 GTTATGAAAATGCTGTTTTCAACATTGTATTTGGACTATGCATGTGTTTTTTCCCCATTGTATATAAAGTACCGCTTAAA 1041 ATTGATATAAATTACTGAGGTTTTTAACATGTATTCTGTTCTTTAAGATCCCTGTAAGAATGTTTAAGGTTTTTATTTAT 1121 TTATATATATTTTTTGAGTCTGTTCTTTGTAAGACATGGTTCTGGTTGTTCGCTCATAGCGGAGAGGCTGGGGCTGCGGT 1201 TGTGGTTGTGGCGGCGTGGGTGGTGGCTGGGAACTGTGGCCCAGGCTTAGCGGCCGCCCGGAGGCTTTTCTTCCCGGAGA 1281 CTGAGGTGGGCGACTGAGGTGGGCGGCTCAGCGTTGGCCCCACACATTCGAGGCTCACAGGTGATTGTCGCTCACACAGT 1361 TAGGGTCGTCAGTTGGTCTGAAACTGCATTTGGCCCACTCCTCCATCCTCCCTGTCCGTCGTAGCTGCCACCCCCAGAGG 1441 CGGCGCTTCTTCCCGTGTTCAGGCGGCTCCCCCCCCCCGTACACGACTCCCAGAATCTGAGGCAGAGAGTGCTCCAGGCT 1521 CGCGAGGTGCTTTCTGACTTCCCCCCAAATCCTGCCGCTGCCGCGCAGCATGTCCCGTGTGGCGTTTGAGGAAATGCTGA 1601 GGGACAGACACCTTGGAGCACCAGCTCCGGTCCCTGTTACAGTGAGAAAGGTCCCCCACTTCGGGGGATACTTGCACTTA 1681 GCCACATGGTCCTGCCTCCCTTGGAGTCCAGTTCCAGGCTCCCTTACTGAGTGGGTGAGACAAGTTCACAAAAACCGTAA 1761 AACTGAGAGGAGGACCATGGGCAGGGGAGCTGAAGTTCATCCCCTAAGTCTACCACCCCCAGCACCCAGAGAACCCACTT 1841 TATCCCTAGTCCCCCAACAAAGGCTGGTCTAGGTGGGGGTGATGGTAATTTTAGAAATCACGCCCCAAATAGCTTCCGTT 1921 TGGGCCCTTACATTCACAGATAGGTTTTAAATAGCTGAATACTTGGTTTGGGAATCTGAATTCGAGGAACCTTTCTAAGA 2001 AGTTGGAAAGGTCCGATCTAGTTTTAGCACAGAGCTTTGAACCTTGAGTTATAAAATGCAGAATAATTCAAGTAAAAATA 2081 AGACCACCATCTGGCACCCCTGACCAGCCCCCATTCACCCCATCCCAGGAGGGGAAGCACAGGCCGGGCCTCCGGTGGAG 2161 ATTGCTGCCACTGCTCGGCCTGCTGGGTTCTTAACCTCCAGTGTCCTCTTCATCTTTTCCACCCGTAGGGAAACCTTGAG 2241 CCATGTGTTCAAACAAGAAGTGGGGCTAGAGCCCGAGAGCAGCAGCTCTAAGCCCACACTCAGAAAGTGGCGCCCTCCTG 2321 GTTGTGCAGCCTTTTAATGTGGGCAGTGGAGGGGCCTCTGTTTCAGGTTATCCTGGAATTCAAAACGTTATGTACCAACC 2401 TCATCCTCTTTGGAGTCTGCATCCTGTGCAACCGTCTTGGGCAATCCAGATGTCGAAGGATGTGACCGAGAGCATGGTCT 2481 GTGGATGCTAACCCTAAGTTTGTCGTAAGGAAATTTCTGTAAGAAACCTGGAAAGCCCCAACGCTGTGTCTCATGCTGTA 2561 TACTTAAGAGGAGAAGAAAAAGTCCTATATTTGTGATCAAAAAGAGGAAACTTGAAATGTGATGGTGTTTATAATAAAAG 2641 ATGGTAAAACTACTTGGATTCAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | MCF7 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903828 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_9124 |
Location of target site | NM_001079846 | 3UTR | AGAAGAAGCCUUCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001079846 | 3UTR | AGACCAUGCUAAUGUUACUAGAGAAGAAGCCUUCUUUUCUUUCUUCUAUGUGAAACUUGAAAUGAGGAAAAGCAAUUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001079846 | 3UTR | ACUAGAGAAGAAGCCUUCUUUUCUUUCUUCUAUGUGAAACUUGAAAUGAGGAAAAGCAAUUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000262367.5 | 3UTR | AUCACUCUUAGACCAUGCUAAUGUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT039584 | CDC14A | cell division cycle 14A | 1 | 1 | ||||||||
MIRT039585 | AGO1 | argonaute 1, RISC catalytic component | 2 | 3 | ||||||||
MIRT039586 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 1 | 1 | ||||||||
MIRT039587 | LRP6 | LDL receptor related protein 6 | 1 | 1 | ||||||||
MIRT071876 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT097443 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 4 | ||||||||
MIRT100100 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT147692 | CBX4 | chromobox 4 | 2 | 2 | ||||||||
MIRT408248 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT442047 | LRAT | lecithin retinol acyltransferase | 2 | 2 | ||||||||
MIRT444412 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT452599 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT469515 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 8 | ||||||||
MIRT498192 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT500151 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT507319 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT508343 | ZNF273 | zinc finger protein 273 | 2 | 6 | ||||||||
MIRT520480 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT522461 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT547116 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548675 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT553756 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 4 | ||||||||
MIRT559437 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT610490 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT644682 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT658214 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT756083 | TP53 | tumor protein p53 | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|